19-Jun-2012 - Johnson & Johnson

Johnson & Johnson Announces Completion of Synthes Acquisition

Johnson & Johnson announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson.

Under the terms of the agreement, each share of Synthes common stock will be exchanged for CHF 55.65 in cash and 1.7170 shares of Johnson & Johnson common stock.  Cash will be provided for fractional shares.

Facts, background information, dossiers
  • Synthes
  • Johnson & Johnson
  • acquisitions
More about Johnson & Johnson
More about Synthes
  • News

    Kuros and Synthes Inc. announce license and development agreement

    Kuros Biosurgery AG has signed a license and development agreement with Synthes, Inc.. Under the terms of the agreement Synthes and Kuros will work together to commercialize Kuros’ synthetic matrix technology in certain fields.Commenting on today’s announcement, Mr. Didier Cowling, CEO of K ... more

  • Companies

    Synthes GmbH

    The DePuy Synthes Companies are part of the Johnson & Johnson Family of Companies. We offer the world’s most comprehensive portfolio of orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools ... more